Detailed answers about MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED, including incorporation, status, business activity, and accounts information.
When was MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED founded?
MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED was officially incorporated on 3 June 2015 and is registered under company number 09622645. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED?
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED?
MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED do?
MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED's registered address?
The registered office address of MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED is GEORGE COURT, BARTHOLEMEWS WALK, ELY, CAMBRIDGESHIRE, UNITED KINGDOM, CB7 4JW. This is the official address filed with Companies House for legal and statutory correspondence.
Is MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED financially stable?
The most recent accounts for MEDICINES DEVELOPMENT FOR GLOBAL HEALTH LIMITED were made up to 30 June 2025, filed as TOTAL EXEMPTION FULL. Next accounts are due by 31 March 2027.